SYNLAB (SYAB.DE) Financial Analysis & Valuation | Quarter Chart
SYNLAB (SYAB.DE)
SYAB.DEPrice: $12.77
Fair Value: 🔒
🔒score
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veteri... more
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hosp... more
Description
Shares
| Market Cap | $2.81B | Exchange | XETRA |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | DE | CEO | Mathieu Floreani |
| IPO Date | 2021-04-30 | CAGR | 0.15% |
| Employees | 27,000 | Website | www.synlab.com |
| Div. Yield | — | Payout Ratio | 0.83% |
| Buy Back Yield | — | Total Yield | — |
SYAB.DE chart loading...
Fundamentals
Technicals
| Enterprise Value | $3.74B | P/E Ratio | 27.65 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.85 | P/B Ratio | 0.97 |
| P/CF Ratio | 6.23 | P/FCF Ratio | 9.55 |
| EPS | $0.46 | EPS Growth 1Y | — |
| EPS Growth 3Y | -80.59% | EPS Growth 5Y | — |
| Revenue Growth 1Y | -9.57% | Gross Margin | 0.22% |
| Operating Margin | 0.04% | Profit Margin | 0.04% |
| ROE | 0.11% | ROA | 0.02% |
| ROCE | 0.03% | Current Ratio | 1.16 |
| Quick Ratio | 1.06 | Cash Ratio | 0.32 |
| Debt/Equity | 0.67 | Interest Coverage | 1.09 |
| Altman Z Score | 1.08 | Piotroski Score | 5 |